ABSTRACT
How human respiratory physiology and the transport phenomena associated with the inhaled airflow therein proceed to impact transmission of SARS-CoV-2, leading to the initial infection, is an open ques- tion. An answer can help determine the susceptibility of an individual on exposure to a COVID-2019 car- rier and can also quantify the still-unknown infectious dose for the disease. Synergizing computational fluid mechanics enabled tracking of respiratory transport in medical imaging-based anatomic domains, with sputum assessment data from hospitalized COVID-19 patients and earlier measurements of ejecta size distribution during regular speech – this study shows that the regional deposition of virus-laden inhaled droplets at the initial nasopharyngeal infection sites peaks for the droplet size range of 2.5 – 19 microns, and reveals that the number of virions that go on to establish the infection can be merely in the order of hundreds.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This material is based upon work supported by the National Science Foundation (NSF), under Award Number 2028069 (PI: author S Basu) for COVID-19 research. Any opinions, findings, and conclusions or recommendations expressed here are, however, those of the author and do not necessarily reflect NSF's views. Supplemental assistance for this project came from SB's faculty start-up package at SDSU.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Institutional Review Board at the University of North Carolina at Chapel Hill
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
New details have been added to the Methods section, to clarify the anatomic reconstruction techniques. The sections on results and on discussions have been reviewed and in parts re-drafted to ensure better comprehension by the reader. The reference list has been revised and updated as well.
Data Availability
This project has generated simulated quantitative, de-identified data on regional deposition along nasal tissues. The data-sets (including Fluent .cas and .dat files) and the numeric protocols; along with MATLAB codes, Wolfram Mathematica notebooks, and Microsoft Excel spreadsheets used for data post-processing - are available from the corresponding author on request, through a shared-domain Google Drive folder (see the reference list).
https://drive.google.com/drive/folders/1OnEo_fPtSzIqG5_VLKpsg3L5ixG108cI?usp=sharing
